Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
NVision develops quantum computing and quantum-enhanced sensing platforms based on quantum spin control in organic molecules, with focus on healthcare applications including drug development and disease treatment.
4 investors
Ocular is a clinical-stage biopharmaceutical company developing AXPAXLI (OTX-TKI), an investigational axitinib intravitreal hydrogel, aimed at reducing the treatment burden of retinal diseases. Its lead therapy is in Phase 3 clinical trials for wet AMD, with additional focus on diabetic retinopathy.
4 investors
OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data. The platform serves healthcare systems, pharmaceutical companies, and research organizations seeking to close evidence gaps and improve clinical decision-making.
4 investors
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages. The company operates as a clinical-stage biopharmaceutical firm advancing multiple programs toward regulatory approval and patient access.
4 investors
OneImaging offers an employer-sponsored medical imaging benefit that connects members to a national network of 4,800+ accredited radiology centers with upfront pricing and care navigation support. It integrates with members' existing insurance and negotiates lower rates for scans such as MRI, CT, ultrasound, mammograms, and X-rays to reduce out-of-pocket imaging costs.
4 investors
Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions. Its products focus on soft tissue attachment, avoiding aseptic loosening, and patient-specific reconstruction for surgeons and their patients, including pediatric bone tumor cases.
4 investors
OraPharma develops pharmaceutical products and tools for dental professionals to address oral health concerns, serving dental practices and patients. The company provides educational resources and partners with dental service organizations and academic institutions.
4 investors
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.
4 investors
Orbis Diagnostics is developing a point-of-care diagnostics platform that produces blood test results from a single fingerstick of blood. The product targets clinical blood testing in the medical diagnostics field.
4 investors
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies for genetic and other severe diseases, including rare inherited conditions such as ADA-SCID and metachromatic leukodystrophy. The Nasdaq-listed biotech (ticker ORTX) has commercialized therapies including Strimvelis and Libmeldy in Europe.
4 investors
Orpyx develops a wearable system with smart footbeds, a receiver, and hub that provides real-time plantar pressure monitoring and alerts to help individuals with impaired protective sensation prevent foot ulcers and complications. The system is designed for people at risk of diabetic and neuropathic foot complications, with optional remote monitoring services provided by nursing staff.
4 investors
Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.
4 investors
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.
4 investors
Output builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.
4 investors
PENTAS is a Japanese medical device company holding first-class medical device manufacturing and sales licenses as well as licenses to sell highly controlled medical devices. It is based in Kawasaki, Japan.
4 investors
PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications. The company operates globally with a focus on enabling scientific discovery and sustainability.
4 investors
Persperion Diagnostics develops touch-based sweat sensing technology for diagnostic measurement.
4 investors
Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices. Its initial application is prosthetic limb control for people with upper and lower limb difference, with future uses in robotics and human augmentation.
4 investors
PhenoTips provides a genomic health record and EHR-integrated platform for managing patient pedigrees and genetic analysis. It serves clinical genetics specialists and research teams to facilitate collaborative diagnosis through family history tracking and gene/diagnosis suggestions.
4 investors
PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
4 investors
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification. The devices use a transfemoral, low-profile catheter approach aimed at short procedures and hospitalization for cardiac patients.
4 investors
Pirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications. The company is advancing clinical-stage programs in naloxone, epinephrine, promethazine, and methotrexate while scaling U.S. automated manufacturing and securing IP protection through 2045.
4 investors
Prenuvo operates whole-body MRI scanning clinics for early detection of cancer and diseases, offering fast, safe, non-invasive screening. The company serves health-conscious consumers seeking preventative health screening across North America.
4 investors
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.
4 investors